Selected article for: "efficacy trial and vaccine trial"

Author: Metzger, Vincent T.; Lloyd-Smith, James O.; Weinberger, Leor S.
Title: Autonomous Targeting of Infectious Superspreaders Using Engineered Transmissible Therapies
  • Document date: 2011_3_17
  • ID: 0gt21051_10
    Snippet: For the vaccine, the model assumes optimistic immunization coverage (80% or 95% coverage) of both high-risk and low-risk populations and considers a vaccine that is 30% protective, slightly higher than reported in the recent 'Thai trial' [34] , or a hypothetical 50% protective vaccine; life-long efficacy is assumed for both vaccines (i.e. no HIV mutational escape) but not for the TIP. For the TIPs, we analyze interventions that generate a 0.5-Log.....
    Document: For the vaccine, the model assumes optimistic immunization coverage (80% or 95% coverage) of both high-risk and low-risk populations and considers a vaccine that is 30% protective, slightly higher than reported in the recent 'Thai trial' [34] , or a hypothetical 50% protective vaccine; life-long efficacy is assumed for both vaccines (i.e. no HIV mutational escape) but not for the TIP. For the TIPs, we analyze interventions that generate a 0.5-Log to 1.5-Log viral-load reduction in vivo, as reported in a recent HIV gene-therapy trial [17] . The model predicts the effects of vaccination or TIP intervention on HIV/AIDS prevalence in a resource-poor sub-Saharan setting.

    Search related documents:
    Co phrase search for related documents
    • low risk and protective vaccine: 1
    • low risk and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
    • low risk and viral load reduction: 1, 2
    • low risk high risk and viral load: 1
    • mutational escape and tip intervention: 1
    • protective vaccine and tip intervention: 1, 2, 3, 4
    • protective vaccine and tip intervention vaccination: 1
    • protective vaccine and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • protective vaccine and viral load reduction: 1, 2, 3, 4, 5
    • tip intervention and viral load: 1, 2, 3, 4
    • tip intervention and viral load reduction: 1
    • viral load and vivo viral load reduction: 1, 2
    • viral load reduction and vivo viral load reduction: 1, 2